Home » Newsletters » BioWorld Science

BioWorld Science

May 7, 2003

View Archived Issues

New data on the efficacy and safety of vardenafil in erectile dysfunction

S-18886 improves endothelial function in coronary artery disease

Potential noninvasive technique for the detection of Alzheimer's disease

Boehringer Ingelheim presents new cathepsin inhibitors with utility in autoimmune diseases

Porphyrin-based photosensitizers for use in ocular disorders, cancer, etc.

Novel neurotrophic agents prepared and tested at Ortho-McNeil

Schering patent covers new CDK and/or GSK-3beta inhibitors

Bayer researchers describe new PPARalpha agonists and their use in coronary heart disease

Antitumor apoptolidin derivative with enhanced stability

Analgesic agents with neurotensin NT2 receptor-antagonist activity

Roche scientists prepare and test novel COX-2 inhibitors

CytRx expands RNAi collaboration with Massachusetts medical school

Yamanouchi licenses PYM-50028 rights for Japan

Phase I trial of HER-2 Protein AutoVac cleared to begin

Elan: Q1 developments

First-quarter results reported by Aventis

InterMune offers review of Q1 highlights

FDA grants accelerated approval of Iressa for NSCLC

Viventia's first armed antibodies to enter phase I clinical testing

Positive preclinical results reported for new treatment for sepsis

Roscovitine inhibits the proliferation of RPE cells

Cell adhesion inhibitor K-7174 exerts beneficial effects in murine model of Sjogren's syndrome

U.S. approval for Cialis anticipated for second half of 2003

Further positive results from FluINsure challenge study

Riquent NDA filing planned

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...